Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The approach -- using a placebo when a "standard-of-care" vaccine already exists -- is contentious within the biomedical ...

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

The World Health Organization's member countries on Tuesday approved an agreement to better prevent, prepare for and respond to future pandemics in the wake of the devastation wrought by the ...

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

Shares of Moderna surged to lead S&P 500 gainers in early afternoon trading Tuesday, hours after the Food and Drug ...

Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults ...

Advisers to the US Food and Drug Administration voted on Tuesday to recommend COVID-19 vaccine booster shots for Americans 65 ...

The U.S. Food and Drug Administration is changing the way it approves COVID-19 vaccines for Americans — a move that will ...

FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in ...